Evidence map›Paper›PMID 18754810›Full record

ArticleImmunology2009

Essential role of phosphoinositide 3-kinase gamma in eosinophil chemotaxis within acute pulmonary inflammation.

Matthew Thomas, Matthew J Edwards, Elzbieta Sawicka, Nicholas Duggan, Emilio Hirsch, Matthias P Wymann, Charles Owen, Alexandre Trifilieff, Christoph Walker, John Westwick and 1 more

Open access · greenAbstract read
In one paragraph

Article in Immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Class I PI3K Biology.Current topics in microbiology and immunology · 2022
    Article
  3. Article
  4. PI3KFrontiers in immunology · 2020
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Matthew ThomasNovartis Institutes for BioMedical Research, Horsham, West Sussex, United Kingdom. matthew.thomas@pharma.novartis.com
Matthew J Edwards
Elzbieta Sawicka
Nicholas Duggan
Emilio Hirsch
Matthias P Wymann
Charles Owen
Alexandre Trifilieff
Christoph Walker
John Westwick
Peter Finan
Novartis (United Kingdom) · GBNovartis (Switzerland) · CHUniversity of Basel · CHUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We and others have established an important role for phosphoinositide-3 kinase gamma (PI3Kgamma) in the chemotactic responses of macrophages and neutrophils. The involvement of this lipid kinase in allergic inflammatory responses is, however, yet to be fully determined. Here we compare wild-type (WT) and PI3Kgamma(-/-) (KO) mice within a model of ovalbumin (OVA) -specific pulmonary inflammation. Upon OVA aerosol challenge, cell influx into the bronchoalveolar lavage (BAL) fluid consisted of neutrophils, macrophages and, more significantly, eosinophils - which are key effector cells in allergic inflammation. Each population was reduced by up to 80% in KO mice, demonstrating a role for PI3Kgamma in cell infiltration into the airways. The mechanism of reduced eosinophilia was analysed within both development and effector stages of the immune response. Comparable levels of OVA-specific T-cell proliferation and immunoglobulin production were established in both strains. Furthermore, no significant differences between WT and KO chemokine production were observed. Having identified the critical point of PI3Kgamma involvement, KO eosinophil chemotactic dysfunction was confirmed in vitro. These data are the first to demonstrate the vital role of PI3Kgamma in acute allergic inflammation. The profound dependency of eosinophils on PI3Kgamma for pulmonary influx identifies this lipid kinase as an attractive target for the pharmacological intervention of asthma.

Indexed as

Acute DiseaseAnimalsAsthmaB-LymphocytesBronchoalveolar Lavage FluidCD4-Positive T-LymphocytesChemotaxis, LeukocyteClass Ib Phosphatidylinositol 3-KinaseCytokinesDisease Models, AnimalEosinophiliaEosinophilsEpitopes, T-LymphocyteFemaleIsoenzymesMaleClass Ib Phosphatidylinositol 3-KinaseCytokinesEpitopes, T-LymphocyteIsoenzymesOvalbuminPhosphatidylinositol 3-KinasesPik3cg protein, mouse

Identifiers

PMID18754810
PMCPMC2669822
OpenAlexW1968186500

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.